Stockwatch: Is Mallinckrodt Deep Value Pharma?
Litigation, Depressed Sales and Bankruptcy Warning Place Stock In Value Investing Territory
Executive Summary
The pandemic has affected generic pharmaceutical companies more than their branded brethren but accident-prone Mallinckrodt has been hit harder than most.